Patent details

Basic Information

Publication number:

EP1912625

PCT Application Number:

PCT/EP/2006/007839

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP067766782

PCT Publication Number:

WO/2007/017248

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

ITRACONAZOLE COMPOSITIONS WITH IMPROVED BIOAVAILABILITY

French Title of Invention:

COMPOSITIONS D'ITRACONAZOLE PRESENTANT UNE BIODISPONIBILITE AMELIOREE

German Title of Invention:

ITRACONAZOL-ZUSAMMENSETZUNGEN MIT VERBESSERTER BIOVERFÜGBARKEIT

SPC Number:

Dates

Filing date:

08/08/2006

Grant date:

13/04/2016

EP Publication Date:

13/04/2016

PCT Publication Date:

15/02/2007

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

23/04/2008

EP B1 Publication Date:

13/04/2016

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

08/08/2016

Expiration date:

08/08/2026

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

08/08/2006

 

 

Name:

AbbVie Deutschland GmbH & Co KG

Address:

Max-Planck-Ring 2a, 65205 Wiesbaden, Germany (DE)

Name:

Barrier Therapeutics Inc.

Address:

600 College Road East, Suite 3200, Princeton, NJ 08540, United States (US)

Inventor

1

Name:

BERNDL Gunther

Address:

Germany (DE)

2

Name:

MÄGERLEIN Markus

Address:

Germany (DE)

3

Name:

DEGENHARDT Matthias

Address:

Germany (DE)

4

Name:

DISPERSYN Gerrit

Address:

United States (US)

Priority

Priority Number:

595816 P

Priority Date:

08/08/2005

Priority Country:

United States (US)

Classification

Main IPC Class:

A61K 9/14;

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages